Form 8-K - Current report:
SEC Accession No. 0001493152-23-020618
Filing Date
2023-06-09
Accepted
2023-06-08 18:03:42
Documents
13
Period of Report
2023-06-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38884
2 ex99-1.htm EX-99.1 65499
  Complete submission text file 0001493152-23-020618.txt   291925

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ards-20230608.xsd EX-101.SCH 3239
4 XBRL LABEL FILE ards-20230608_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ards-20230608_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3698
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 231003242
SIC: 2834 Pharmaceutical Preparations